Attacking Fatty Buildup at the Source
A novel nanotechnology promises to be the first therapeutic to directly target the liver in the battle against a disease that afflicts roughly a quarter of the global population.
A novel nanotechnology promises to be the first therapeutic to directly target the liver in the battle against a disease that afflicts roughly a quarter of the global population.